Rare peripheral precocious puberty in female

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:650187
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Rare peripheral precocious puberty in females is an uncommon form of precocious puberty in which the early development of secondary sexual characteristics is driven by sex steroid production independent of the hypothalamic-pituitary-gonadal (HPG) axis. Unlike central precocious puberty, where premature activation of the HPG axis triggers puberty, peripheral precocious puberty (also called gonadotropin-independent precocious puberty) results from autonomous estrogen secretion from sources such as ovarian cysts, ovarian tumors (e.g., granulosa cell tumors), adrenal tumors, or exogenous estrogen exposure. In females, this can manifest as breast development (thelarche), vaginal bleeding, accelerated linear growth, and advanced bone age occurring before the age of 8 years. The condition primarily affects the reproductive and endocrine systems. Clinical evaluation typically reveals suppressed gonadotropin levels (LH and FSH) with elevated estradiol, distinguishing it from central precocious puberty. Imaging studies such as pelvic ultrasound and adrenal imaging are essential to identify the underlying cause. Rare genetic conditions such as McCune-Albright syndrome (caused by somatic activating mutations in the GNAS gene) can also present with peripheral precocious puberty in girls due to autonomous ovarian function. Treatment depends on the underlying etiology. Surgical removal of hormone-secreting tumors may be curative. For conditions like McCune-Albright syndrome, aromatase inhibitors (such as letrozole) or selective estrogen receptor modulators (such as tamoxifen) have been used to manage estrogen excess. Monitoring of growth velocity, bone age, and pubertal progression is essential. If peripheral precocious puberty triggers secondary central precocious puberty, GnRH agonist therapy may also be required. Early diagnosis and management are important to prevent psychosocial distress and to optimize adult height potential.

Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Childhood

Begins in childhood, roughly ages 1 to 12

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Rare peripheral precocious puberty in female.

View clinical trials →

No actively recruiting trials found for Rare peripheral precocious puberty in female at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Rare peripheral precocious puberty in female community →

No specialists are currently listed for Rare peripheral precocious puberty in female.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Rare peripheral precocious puberty in female.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Rare peripheral precocious puberty in femaleForum →

No community posts yet. Be the first to share your experience with Rare peripheral precocious puberty in female.

Start the conversation →

Latest news about Rare peripheral precocious puberty in female

No recent news articles for Rare peripheral precocious puberty in female.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Rare peripheral precocious puberty in female

What is Rare peripheral precocious puberty in female?

Rare peripheral precocious puberty in females is an uncommon form of precocious puberty in which the early development of secondary sexual characteristics is driven by sex steroid production independent of the hypothalamic-pituitary-gonadal (HPG) axis. Unlike central precocious puberty, where premature activation of the HPG axis triggers puberty, peripheral precocious puberty (also called gonadotropin-independent precocious puberty) results from autonomous estrogen secretion from sources such as ovarian cysts, ovarian tumors (e.g., granulosa cell tumors), adrenal tumors, or exogenous estrogen

At what age does Rare peripheral precocious puberty in female typically begin?

Typical onset of Rare peripheral precocious puberty in female is childhood. Age of onset can vary across affected individuals.